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The gastrointestinal (GI) tract contains much of
the body’s serotonin (5-hydroxytryptamine, 5-HT),
but mechanisms controlling the metabolism of gut-
derived 5-HT remain unclear. Here, we demonstrate
that the microbiota plays a critical role in regulating
host 5-HT. Indigenous spore-forming bacteria (Sp)
from the mouse and human microbiota promote 5-
HT biosynthesis from colonic enterochromaffin cells
(ECs), which supply 5-HT to the mucosa, lumen, and
circulating platelets. Importantly, microbiota-depen-
dent effects on gut 5-HT significantly impact host
physiology, modulating GI motility and platelet func-
tion. We identify select fecal metabolites that are
increased by Sp and that elevate 5-HT in chromaffin
cell cultures, suggesting direct metabolic signaling
of gut microbes to ECs. Furthermore, elevating
luminal concentrations of particularmicrobial metab-
olites increases colonic and blood 5-HT in germ-free
mice. Altogether, these findings demonstrate that Sp
are important modulators of host 5-HT and further
highlight a key role for host-microbiota interactions
in regulating fundamental 5-HT-related biological
processes.INTRODUCTION
In addition to its role as a brain neurotransmitter, the monoamine
serotonin (5-hydroxytryptamine [5-HT]) is an important regulato-
ry factor in the gastrointestinal (GI) tract and other organ sys-
tems. More than 90% of the body’s 5-HT is synthesized in the
gut, where 5-HT activates as many as 14 different 5-HT receptor
subtypes (Gershon and Tack, 2007) located on enterocytes
(Hoffman et al., 2012), enteric neurons (Mawe and Hoffman,
2013), and immune cells (Baganz and Blakely, 2013). In addition,
circulating platelets sequester 5-HT from the GI tract, releasing it
to promote hemostasis and distributing it to various body sites
(Amireault et al., 2013). As such, gut-derived 5-HT regulates
diverse functions, including enteric motor and secretory reflexes
(Gershon and Tack, 2007), platelet aggregation (Mercado et al.,264 Cell 161, 264–276, April 9, 2015 ª2015 Elsevier Inc.2013), immune responses (Baganz and Blakely, 2013), and bone
development (Chabbi-Achengli et al., 2012; Yadav et al., 2008),
and cardiac function (Coˆte´ et al., 2003). Furthermore, dysregula-
tion of peripheral 5-HT is implicated in the pathogenesis of
several diseases, including irritable bowel syndrome (IBS) (Stasi
et al., 2014), cardiovascular disease (Ramage and Villalo´n, 2008),
and osteoporosis (Ducy and Karsenty, 2010).
The molecular mechanisms controlling the metabolism of
gut 5-HT remain unclear. In the GI tract, 5-HT is synthesized
by specialized endocrine cells, called enterochromaffin cells
(ECs), as well as mucosal mast cells and myenteric neurons
(Gershon and Tack, 2007), but the functions of these different
pools of gut 5-HT are incompletely understood. In addition,
two different isoenzymes of tryptophan hydroxylase (Tph),
Tph1 and Tph2, mediate non-neuronal versus neuronal 5-HT
biosynthesis (Walther et al., 2003), but little is known regarding
the endogenous signals that regulate Tph expression and
activity.
Mammals are colonized by a vast and diverse collection of
microbes that critically influences health and disease. Recent
studies highlight a role for the microbiota in regulating blood
5-HT levels, wherein serum concentrations of 5-HT are substan-
tially reduced in mice reared in the absence of microbial coloni-
zation (germ-free [GF]), compared to conventionally-colonized
(specific pathogen-free [SPF]) controls (Sjo¨gren et al., 2012;Wik-
off et al., 2009). In addition, intestinal ECs are morphologically
larger in GF versus SPF rats (Uribe et al., 1994), which suggests
that microbes could impact the development and/or function of
5-HT-producing cells. Interestingly, some species of bacteria
grown in culture can produce 5-HT (Tsavkelova et al., 2006),
raising the question of whether indigenous members of the mi-
crobiota contribute to host 5-HT levels through de novo synthe-
sis. Based on this emerging link between the microbiota and
serum 5-HT concentrations, we aimed to determine how path-
ways of 5-HT metabolism are affected by the gut microbiota,
to identify specific microbial communities and factors involved
in conferring serotonergic effects, and to evaluate howmicrobial
modulation of peripheral 5-HT impacts host physiology.
Here, we show that the microbiota promotes 5-HT biosyn-
thesis from colonic ECs in a postnatally inducible and reversible
manner. Spore-forming microbes (Sp) from the healthy mouse
and human microbiota sufficiently mediate microbial effects on
serum, colon, and fecal 5-HT levels. We further explore potential
host-microbial interactions that regulate peripheral 5-HT by
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Figure 1. The Gut Microbiota Modulates
Host Peripheral Serotonin Levels
(A) Levels of serum 5-HT. Data are normalized to
serum 5-HT in SPF mice (n = 8–13).
(B) Levels of colon 5-HT relative to total protein.
Data are normalized to colon 5-HT relative to total
protein in SPF mice (n = 8–13).
(C) Colonic expression of TPH1 relative to GAPDH.
Data are normalized to expression levels in SPF
mice (n = 4).
(D) Colonic expression of SLC6A4 relative to
GAPDH. Data are normalized to expression levels in
SPF mice (n = 4).
Data are presented as mean ± SEM. *p < 0.05,
**p < 0.01, ***p < 0.001. n.s., not statistically sig-
nificant; SPF, specific pathogen-free (convention-
ally-colonized); GF, germ-free; CONV., SPF con-
ventionalized; ABX, antibiotic-treated; VEH, vehicle
(water)-treated.
See also Figure S1.surveying microbial influences on the fecal metabolome. We find
that particular microbial metabolites are elevated by Sp and
likely signal directly to colonic ECs to promote 5-HT biosyn-
thesis. Importantly, microbiota-mediated changes in colonic 5-
HT regulate GI motility and hemostasis in the host, suggesting
that targeting the microbiota can serve as a tractable approach
for modulating peripheral 5-HT bioavailability and treating 5-
HT-related disease symptoms.
RESULTS
The Gut Microbiota Modulates Host Peripheral
Serotonin Levels
Adult GF mice display deficient serum (Sjo¨gren et al., 2012; Wik-
off et al., 2009) (Figure 1A) and plasma (Figure S1A) 5-HT con-
centrations compared to SPF controls, but the cellular sources
of this disruption are undefined. Consistent with the understand-
ing that much of the body’s 5-HT derives from the GI tract, we
find that GFmice exhibit significantly decreased levels of colonic
and fecal 5-HT compared to SPF controls (Figures 1B and S1A;
Table S1). This deficit in 5-HT is observed broadly across
the distal, medial and proximal colon (Figure S1D), but not in
the small intestine (Figures S1A, S2A, and S2B), suggesting a
specific role for the microbiota in regulating colonic 5-HT.
Decreased levels of 5-HT are localized to colonic chromogranin
A-positive (CgA+) enterochromaffin cells (ECs) (Figure 2), and
not to small intestinal ECs (Figures S2A and S2B). Low 5-HT
signal is seen in both GF and SPF colonic mast cells and entericCell 161, 264neurons (Figure 2A), which are minor pro-
ducers of 5-HT (Gershon and Tack,
2007). There is no difference between
adult GF and SPF mice in the abundance
of CgA+ ECs (Figure 2C), suggesting that
decreases in colon 5-HT result from
abnormal 5-HT metabolism rather than
impaired development of ECs.
To identify the specific steps of 5-HT
metabolism that are affected by themicro-biota, key intermediates of the 5-HT pathway were assessed in
colons from GF versus SPF mice. We find that GF colons exhibit
decreased expression of TPH1 (Figures 1C and S1D) (Sjo¨gren
et al., 2012), the rate-limiting enzyme for 5-HT biosynthesis in
ECs, but no difference in expression of enzymes involved in 5-
HT packaging, release and catabolism (Figure S1C). GF mice
also display elevated colonic expression of the 5-HT transporter
SLC6A4 (Figures 1D and S1E) (Sjo¨gren et al., 2012), synthesized
broadly by enterocytes to enable 5-HT uptake (Wade et al.,
1996). This could reflect a compensatory response to deficient
5-HT synthesis by host ECs, based on the finding that chemical
Tph inhibition modulates SLC6A4 expression (Figures S2C and
S2D). There is no difference betweenGF and SPFmice in colonic
expression of neural-specific isoforms of 5-HT enzymes (Fig-
ure S1F), consistent with data showing no apparent difference
in 5-HT-specific staining in enteric neurons (Figure 2). Despite
deficient levels of colon, fecal, and serum 5-HT (Figures 1A,
1B, and S1A; Table S1), GF mice exhibit significantly increased
levels of the Tph substrate, tryptophan (Trp), in both feces (Table
S1) and serum (Sjo¨gren et al., 2012; Wikoff et al., 2009), suggest-
ing that primary disruptions in host TPH1 expression result in Trp
accumulation. Oral supplementation of GF mice with the Tph
product, 5-hydroxytryptophan (5-HTP), sufficiently ameliorates
deficits in colon and serum 5-HT, whereas supplementation
with the Tph substrate Trp has no restorative effect (Figures
S1G–S1I). Collectively, these data support the notion that themi-
crobiota promotes 5-HT biosynthesis by elevating TPH1 expres-
sion in colonic ECs.–276, April 9, 2015 ª2015 Elsevier Inc. 265
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Figure 2. Indigenous Spore-Forming Bacteria Increase 5-HT Levels in Colon Enterochromaffin Cells
(A) Representative images of colons stained for chromogranin A (CgA) (left), 5-HT (center), and merged (right). Arrows indicate CgA-positive cells that lack 5-HT
staining (n = 3–7 mice/group).
(B) Quantitation of 5-HT+ cell number per area of colonic epithelial tissue (n = 3–7 mice/group).
(C) Quantitation of CgA+ cell number per area of colonic epithelial tissue (n = 3–7 mice/group).
(D) Ratio of 5-HT+ cells/CgA+ cells per area of colonic epithelial tissue (n = 3–7 mice/group).
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. SPF, specific pathogen-free (conventionally-colonized); GF, germ-free;
CONV., SPF conventionalized; ABX, antibiotic-treated; Sp, spore-forming bacteria; PCPA, para-chlorophenylalanine.
See also Figure S2.To confirm that deficient 5-HT levels in GF mice are micro-
biota-dependent and further determine whether effects are
age-dependent, GF mice were conventionalized with an SPF
microbiota at birth (postnatal day [P] 0), weaning (P21), or early
adulthood (P42) and then evaluated at P56 for levels of 5-HT
and expression of 5-HT-related genes. GF mice conventional-
ized at each age with an SPF microbiota exhibit restored
serum (Figure 1A) and colon (Figure 1B) 5-HT levels, with
more pronounced effects seen at earlier ages of colonization.
Colonic expression of TPH1 and SLC6A4 is similarly corrected
by postnatal conventionalization of GF mice (Figures 1C and
1D), with more substantial changes from P0 conventionaliza-
tion. Increases in 5-HT are localized to colonic ECs (Figure 2).
These findings indicate that postnatal reconstitution of the gut
microbiota can correct the 5-HT deficiency seen in GF mice
and further suggest that gut microbes exert a continuous ef-
fect on 5-HT synthesis by modulating EC function. Overall,
we demonstrate that microbiota-mediated elevation of host
5-HT is postnatally inducible, persistent from the time of266 Cell 161, 264–276, April 9, 2015 ª2015 Elsevier Inc.conventionalization and not dependent on the timing of host
development.
To assess the reversibility of microbial effects on host 5-HT
metabolism, we depleted the gut microbiota in SPF mice via
bi-daily antibiotic treatment beginning on P0, P21, or P42 and
until P56. Treatment of P42 SPF mice with a cocktail of ampi-
cillin, vancomycin, neomycin, and metronidazole (Reikvam
et al., 2011) sufficiently recapitulates GF-associated deficits in
serum and colon 5-HT and alterations in host colonic TPH1
and SLC6A4 expression (Figures 1 and 2). Interestingly, P0
and P21 antibiotic treatment also induces GF-related deficits in
colonic 5-HT, but the effects on serum 5-HT are more pro-
nounced when administered at P42, compared to P0 and P21
(Figure 1), suggesting potential confounding effects of early life
or prolonged antibiotic treatment on microbiota-mediated mod-
ulation of peripheral 5-HT. Antibiotics can elicit several direct ef-
fects on host cells (Shimizu et al., 2003; Westphal et al., 1994),
which may underlie differences between P0 treatment and
GF status. That P42 antibiotic treatment of SPF mice results in
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Figure 3. Indigenous Spore-Forming Bacte-
ria Induce Colon 5-HT Biosynthesis and Sys-
temic 5-HT Bioavailability
(A) Levels of serum 5-HT. Data are normalized to
serum 5-HT levels in SPFmice. SPF, n = 13; GF, n =
17; GF+conv, P21 conventionalization, n = 4;
SPF+Abx, P42 antibiotic treatment, n = 7; B. fragilis
monoassociation (BF), n = 6; SFB, Segmented
Filamentous Bacteria monoassociation, n = 4; ASF,
Altered Schaedler Flora P21 colonization, n = 4; Sp,
spore-forming bacteria, P21 colonization, n = 4;
B. uniformis P21 colonization, n = 4; Bd, Bacter-
oides consortium, n = 3.
(B) Levels of colon 5-HT relative to total protein.
Data are normalized to colon 5-HT relative to total
protein in SPF mice (n = 5–15).
(C) Levels of colon 5-HT relative to total protein after
intrarectal treatment with the Tph inhibitor, PCPA,
or vehicle (n = 4).
(D) Colonic expression of TPH1 relative to GAPDH.
Data are normalized to expression levels in SPF
mice (n = 3).
Data are presented as mean ± SEM. *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001. n.s., not
statistically significant; SPF, specific pathogen-
free (conventionally-colonized); GF, germ-free;
Sp, spore-forming bacteria; PCPA, para-chlor-
ophenylalanine.
See also Figure S3.5-HT phenotypes analogous to those seen in GF mice demon-
strates that microbiota effects on host 5-HT can be abrogated
postnatally and further supports the plasticity of 5-HT modula-
tion by indigenous gut microbes. Altogether, these data indicate
that the gut microbiota plays a key role in raising levels of colon
and serum 5-HT, by promoting 5-HT in colonic ECs in an induc-
ible and reversible manner.
Indigenous Spore-Forming Microbes Promote Host
Serotonin Biosynthesis
In light of our finding that 5-HT levels are decreased in colons
but not small intestines of GF mice compared to SPF controls,
we hypothesized that specific subsets of gut microbes are
responsible for affecting host 5-HT pathways. Mice mono-
colonized with Bacteroides fragilis or Segmented Filamentous
Bacteria (SFB) display deficits in serum 5-HT that are compara-
ble to those seen in GF mice (Figure 3A). Moreover, postnatal
colonization (P21) with Bacteroides uniformis, altered Schae-
dler flora (ASF), an eight-microbe consortium known to correct
gross intestinal pathology in GF mice (Dewhirst et al., 1999), or
with cultured Bacteroides spp. from the SPF mouse microbiota,
has no significant effect on the 5-HT deficiency seen in GF mice
(Figures 3A and 3B). Interestingly, however, GF mice colonized
at P42 with indigenous spore-forming microbes from the
mouse SPF microbiota (Sp), known to be dominated by Clos-
tridial species (Atarashi et al., 2013; Stefka et al., 2014) (Table
S2), exhibit complete restoration of serum and colon 5-HT to
levels observed in SPF mice (Figures 3A and 3B). Consistent
with this, Sp colonization of GF mice increases 5-HT stainingcolocalized to CgA+ ECs (Figure 2), elevates host colonic
TPH1 expression (Figure 3D) and decreases SLC6A4 expres-
sion (Figure 3E) toward levels seen in SPF mice. Improvements
in serum 5-HT are observed within 2 days after inoculation of
GF mice with Sp (Figure S2E) and do not correlate with amelio-
ration of abnormal cecal weight (Figure S2F). Importantly, Sp
also elevates colonic 5-HT in Rag1 knockout mice (Figure S2G),
which lack adaptive immune cells, indicating that the effects of
Sp on gut 5-HT are not dependent on Sp-mediated regulatory
T cell induction (Stefka et al., 2014). Notably, the 5-HT-promot-
ing effects of Sp are recapitulated by colonization of GF mice
with spore-forming microbes from the healthy human colonic
microbiota (hSp) (Figure S3), suggesting that the serotonergic
function of this community is conserved across mice and
humans.
To determine whether the effects of Sp on host 5-HT depend
on colonic Tph activity, we colonized GF mice with Sp on
P42 and then administered the Tph inhibitor para-chloropheny-
lalanine (PCPA) intrarectally twice daily for 3 days prior to 5-HT
assessments on P56 (Liu et al., 2008). Intrarectal injection of
PCPA sufficiently blocks the ability of Sp to elevate colon
and serum 5-HT levels (Figures 3C andS2C), aswell as Sp-medi-
ated increases in 5-HT staining in ECs (Figure 2). Similar effects
of PCPA treatment on blocking increases in colon 5-HT, serum
5-HT, and 5-HT staining in colonic ECs are seen in GF
mice colonized with hSp (Figure S3). Interestingly, inhibiting
Tph activity with PCPA results in a compensatory increase in
colonic TPH1 and decrease in SLC6A4 (Figures 3D and S2D)
expression in Sp-colonized mice, supporting the notion thatCell 161, 264–276, April 9, 2015 ª2015 Elsevier Inc. 267
microbiota-dependent changes in 5-HT transporter levels occur
as a secondary response to Tph modulation.
To further evaluate whether changes in SLC6A4 expression
are necessary for microbiota-mediated alterations in peripheral
5-HT, we tested the effects of microbiota manipulations on colon
and serum 5-HT in SLC6A4 heterozygous (+/) and complete
(/) knockout (KO) mice. Depleting the microbiota via P42-
P56 antibiotic treatment (Reikvam et al., 2011) of SPFSLC6A4+/
and SLC6A4/ mice effectively decreases colonic 5-HT levels
(Figures S4A and S4B), indicating that the microbiota is required
for promoting gut 5-HT in Slc6a4-deficient mice. Colonizing anti-
biotic-treated SLC6A4+/ and SLC6A4/ mice with Sp raises
colon 5-HT to levels seen in untreated SPF SLC6A4+/ and
SLC6A4/ mice (Figure S4A), demonstrating that Slc6a4 is
not required for conferring the effects of Sp on gut 5-HT. Antibi-
otic-induced decreases and Sp-induced increases in colon 5-HT
levels can be attributed to modulation of 5-HT content in colonic
ECs from SLC6A4+/ and SLC6A4/mice (Figure S4C). Similar
effects of antibiotic treatment and Sp colonization are seen for
serum 5-HT in SLC6A4+/ mice, whereas SLC6A4/ mice
exhibit low to undetectable levels of serum 5-HT, highlighting
the dependence of platelets on Slc6a4-mediated 5-HT uptake
(Figure S4B). Taken together, these data support a role for Sp
in promoting Tph1-mediated 5-HT biosynthesis by colonic
ECs, regulating both colon and serum levels of 5-HT.
Microbiota-Mediated Regulation of Host Serotonin
Modulates Gastrointestinal Motility
Intestinal 5-HT plays an important role in stimulating the enteric
nervous system and GI function (Gershon and Tack, 2007). To
determine whether microbiota-dependent modulation of colonic
5-HT impacts GI motility, we colonized P42 GFmice with Sp and
then tested for GI transit and colonic neuronal activation at P56.
Sp colonization ameliorates GF-associated abnormalities in GI
motility, significantly decreasing total transit time and increasing
the rate of fecal output in a Tph-dependent manner (Figures 4A
and 4B). Similar effects are seen in SLC6A4+/ and SLC6A4/
mice, where Sp colonization of antibiotic-treated mice restores
GI transit time toward levels seen in untreated SPF SLC6A4+/
and SLC6A4/ controls (Figure S4E).
Consistent with deficits in GI motility, steady-state activation
of 5-HT receptor subtype 4 (5HT4)-expressing cells in the colonic
submucosa and muscularis externa is decreased in GF mice
compared to SPF controls, as measured by colocalized expres-
sion of 5HT4 with the immediate early gene, c-fos (Figures 4C–
4E). Colonization of GF mice with Sp increases 5HT4+ c-fos+
staining to levels seen in SPF mice, and this effect is dependent
on colonic Tph activity (Figures 4C–4E), which aligns well with
the understanding that Sp-induced elevations in colonic 5-HT
promote GI motility by activation of 5HT4+ enteric neurons
(Mawe and Hoffman, 2013). In addition, colonic activation of
intrinsic afferent primary neurons (IPANs) of themyenteric plexus
is decreased in GF mice (McVey Neufeld et al., 2013) and
improved by colonization with Sp, asmeasured by colocalization
of c-fos and the IPANmarker, calretinin (Calb2) (Figure 4F). Inhib-
iting Tph activity with PCPA decreases IPAN activation in Sp-
colonized mice, suggesting that some IPAN responses to Sp
depend on host 5-HT synthesis (Figure 4F). Altogether, these268 Cell 161, 264–276, April 9, 2015 ª2015 Elsevier Inc.findings indicate that Sp-mediated increases in colonic 5-HT
biosynthesis are important for gut sensorimotor function.
Microbiota-Mediated Regulation of Host Serotonin
Modulates Platelet Function
Platelets uptake gut-derived 5-HT and release it at sites of vessel
injury to promote blood coagulation. To determine if microbiota-
dependent modulation of colon (Figures 1 and 3) and plasma
(Figure S1A) 5-HT impacts platelet function, we colonized P42
mice with Sp and then examined blood clotting, platelet activa-
tion and platelet aggregation at P56. In a tail bleed assay (Liu
et al., 2012), GF mice exhibit trending increases in time to cessa-
tion of bleeding compared to SPF mice, suggesting impaired
blood coagulation (Figure 5A). Colonization of GF mice with Sp
ameliorates abnormalities in bleeding time to levels seen in
SPF controls, and this effect is attenuated by intrarectal admin-
istration of PCPA (Figure 5A), indicating that Sp-mediated im-
provements in coagulation may be dependent on colonic Tph
activity. Notably, the impact of acute colonic PCPA treatment
on reducing 5-HT content and 5-HT-related functions in platelets
may be tempered by the fact that mouse platelets have a lifespan
of 4 days (Odell and McDonald, 1961). There were no signifi-
cant differences between treatment groups in total platelet
counts (Figure S5A).
In light of inherent limitations of the tail bleed assay (Liu
et al., 2012), we focused subsequent experiments particularly on
platelet activity.Platelets isolated fromGFmicedisplaydecreased
activation in response to in vitro type I fibrillar collagen stimulation,
as measured by reduced surface expression of the activation
markers granulophysin (CD63), P-selectin, and JON/A (integrin
aIIbb3) (Figures 5D–5F) (Ziu et al., 2012). Sp colonization of GF
mice leads to partial restoration in the expression of platelet acti-
vation markers, and this effect depends on colonic Tph activity
(Figures 5D–5F).Moreover, platelets isolated fromGFmice exhibit
impaired aggregation in response to in vitro collagen stimulation,
as measured by decreased levels of high granularity, high mass
aggregates detected by both flow cytometry (De Cuyper et al.,
2013; Nieswandt et al., 2004) (Figures 5B, 5C, S5C, and S5D)
and imaging (Figure S5B). Colonization of GF mice with Sp re-
stores levels of platelet aggregation to those seen in SPF mice.
These effects of Sp on correcting impaired platelet aggregation
are attenuated by colonic PCPA injection, indicating dependence
on Tph activity. Overall, these findings suggest that Sp-mediated
elevations in colonic 5-HT, and thus platelet 5-HT, promote
platelet activation and aggregation relevant to hemostasis.
Microbial Metabolites Mediate Effects of theMicrobiota
on Host Serotonin
In light of the important role for Sp in regulating 5-HT-related in-
testinal and platelet function, we aimed to identify specificmicro-
bial factors responsible for conferring the serotonergic effects of
Sp. Based on our finding that Sp elevates 5-HT particularly in
colonic ECs (Figure 2), we hypothesized that Sp promotes levels
of a soluble factor that signals directly to ECs to modulate TPH1
expression and 5-HT biosynthesis. To test this, we prepared fil-
trates of total colonic luminal contents from Sp-colonized mice
and controls and evaluated their effects on levels of 5-HT in
RIN14B chromaffin cell cultures (Nozawa et al., 2009). Relative
Figure 4. Microbiota-Mediated Regulation of Host Serotonin Modulates Gastrointestinal Motility
(A) Total time for transit of orally administered carmine red solution through the GI tract (n = 4–8).
(B) Defecation rate as measured by number of fecal pellets produced relative to total transit time (n = 4–8).
(C) Representative images of c-fos and 5HT4 colocalization in the colonic submucosa and muscularis externa (n = 4–5 mice/group).
(D) Quantitation of total c-fos fluorescence intensity in the colonic submucosa and muscularis externa (n = 4–5 mice/group).
(E) Quantitation of total 5HT4 fluorescence intensity in the colonic submucosa and muscularis externa (n = 4–5 mice/group).
(F) Quantitation and representative images of c-fos and calb2 (calretinin) colocalization in the colonic submucosa and muscularis externa (n = 5–8 mice/group).
Data are presented asmean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. SPF, specific pathogen-free (conventionally-colonized); GF, germ-free; Sp,
spore-forming bacteria; PCPA, para-chlorophenylalanine.
See also Figure S4.to vehicle-treated controls, there is no significant effect of filtered
colonic luminal contents fromGFmice on levels of 5-HT released
or TPH1 expressed from RIN14B cells (Figures 6A and 6B).Filtered colonic luminal contents from SPF and Sp-colonized
mice sufficiently induce 5-HT from RIN14B cells (Figure 6A), to
levels comparable to those elicited by the calcium ionophore,Cell 161, 264–276, April 9, 2015 ª2015 Elsevier Inc. 269
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Figure 5. Microbiota-Mediated Regulation of Host Serotonin Modulates Hemostasis
(A) Time to cessation of bleeding in response to tail injury (n = 7–16).
(B) Platelet activation, as measured by percentage of large, high granularity (FSChigh, SSChigh) events after collagen stimulation relative to unstimulated controls
(n = 3).
(C) Representative flow cytometry plots of large, high granularity (FSChigh, SSChigh) activated platelets after collagen stimulation (bottom), as compared to un-
stimulated controls (top) (n = 3).
(D–F) Geometric mean fluorescence intensity of granulophysin (CD63) (D), P-selectin (E), and JON/A (integrin aIIbb3) (F) expression in collagen-stimulated
platelets (left). Representative histograms (right) of event count versus fluorescence intensity (log scale) for platelets treatedwith collagen (red line) or vehicle (blue
line) (n = 3).
Data for platelet assays are representative of three independent trials with at least three mice in each group. Data are presented as mean ± SEM. *p < 0.05, **p <
0.01, ***p < 0.001, ****p < 0.0001. n.s., not statistically significant; SPF, specific pathogen-free (conventionally-colonized); GF, germ-free; Sp, spore-forming
bacteria; PCPA, para-chlorophenylalanine.
See also Figure S5.ionomycin, as a positive control. TPH1 expression is also ele-
vated in chromaffin cells exposed to SPF and Sp luminal filtrates,
suggesting increased 5-HT synthesis. This is in contrast to
ionomycin, which stimulates 5-HT release, but has no effect on
TPH1 expression, from RIN14B cells. Importantly, these findings
suggest that microbiota-mediated increases in gut 5-HT are
conferred via direct signaling of a soluble, Sp-modulated factor
to colonic ECs.
We utilized metabolomic profiling to identify candidate Sp-
dependent, 5-HT-inducing molecules in feces from adult mice.
Sp colonization of GF mice leads to statistically significant alter-
ations in 75% of the 416metabolites detected, of which 76% are
elevated and 24% are reduced, relative to vehicle-treated GF
controls (Tables S1 and S3). Similar changes are seen with
hSp colonization, leading to co-clustering of Sp and hSp sam-
ples by principal components analysis (PCA) (Figure 6C). ASF
colonization has a mild effect, significantly modulating 50% of
metabolites detected (66% increased, 36% decreased) (Table
S3), and forming a distinct but proximal cluster to GF controls270 Cell 161, 264–276, April 9, 2015 ª2015 Elsevier Inc.by PCA (Figure 6C). Postnatal conventionalization of GF mice
with an SPF microbiota alters 66% of all metabolites detected
(59% increased, 41% decreased) (Table S3) and produces sub-
stantial changes in themetabolome that are distinguishable from
the effects of Sp, hSp, and ASF along PC2 (Figure 6C). Notably,
Sp, hSp, and SPF colonization results in similar shifts along PC1,
compared to vehicle and ASF-treated controls, suggesting com-
mon metabolic alterations among communities that similarly
elevate peripheral 5-HT levels. Metabolomics profiling confirms
that fecal 5-HT is commonly upregulated in the Sp, hSp, and
SPF fecal metabolome and comparatively low in ASF and GF
samples (Table S1). Simple linear regression reveals 83 metabo-
lites that co-vary with 5-HT (r2 R 0.25), 47 of which correlate
positively and 36 of which correlate negatively with 5-HT levels
(Figure S6A; Table S4).
To determine whether specificmetabolitesmediate the effects
of Sp on 5-HT, we tested a subset of biochemicals that were
commonly upregulated by Sp, hSp, and SPF, and that positively
correlated with 5-HT levels (Figure S6A; Table S4), for their ability
to induce 5-HT in vitro and in vivo. We also tested the short chain
fatty acids, acetate, butyrate, and propionate, which were previ-
ously shown to be produced by Sp (Atarashi et al., 2013) and to
stimulate 5-HT release from ECs (Fukumoto et al., 2003). Of 16
metabolites examined, a-tocopherol, butyrate, cholate, deoxy-
cholate, p-aminobenzoate (PABA), propionate, and tyramine
elevate 5-HT in RIN14B chromaffin cell cultures (Figure 6D). Ele-
vations in 5-HT correspond to increases in TPH1 expression
from RIN14B cells (Figure 6E), suggesting that particular metab-
olites induced by Sp enhance 5-HT biosynthesis by ECs. We
further tested for sufficiency to induce 5-HT in vivo. Notably,
raising luminal concentrations of deoxycholate in colons of GF
mice to levels seen in SPFmice (Sayin et al., 2013) sufficiently in-
creases colon and serum 5-HT compared to vehicle-injected
controls (Figures 6F and S6B). This restoration of peripheral
5-HT correlates with elevations in colonic TPH1 expression (Fig-
ure 6F). Increases in colon and serum 5-HT are also seen with in-
jection of a-tocopherol, PABA and tyramine into colons of GF
mice (Figures S6B and S6C). Consistent with in vitro RIN14B
data, oleanolate has no statistically significant effect on elevating
colon or serum 5-HT in GF mice (Figures S6B and S6C). Impor-
tantly, the effects of a single rectal injection of deoxycholate or
a-tocopherol on raising colon 5-HT levels in GF mice are weak
and transient, peaking within 1 hr of injection (Figure S6C).
Consistent with this, there is no significant effect of acute colonic
metabolite injection on GI transit time (Figure S6D), and there is
only a trending improvement on platelet activation (Figure S6E).
Our finding that Sp colonization leads to lasting increases in co-
lon and blood 5-HT levels (Figure 3), and long-term changes in
the fecal metabolome (Figure 6C; Tables S1 and S3), suggests
that Sp colonization results in persistent elevations of 5-HT-
modulating luminal metabolites. Future studies on whether
chronic, colon-restricted increases in Sp-regulated metabolites
sufficiently correct GI motility and platelet function in GF mice,
and whether this occurs in a 5-HT-dependent manner, are war-
ranted. In addition, we demonstrate that select concentrations of
Sp-associatedmetabolites sufficiently promote 5-HT in vitro and
in vivo, but whether the metabolites are necessary for mediating
the serotonergic effects of Sp is unclear. Overall, these data
reveal that indigenous spore-forming microbes promote 5-HT
biosynthesis from colonic ECs, modulating 5-HT concentrations
in both colon and blood. Furthermore, we identify select micro-
bial metabolites that confer the serotonergic effects of indige-
nous spore-forming microbes, likely by signaling directly to
colonic ECs to promote Tph1 expression and 5-HT biosynthesis.
DISCUSSION
The GI tract is an important site for 5-HT biosynthesis, but the
regulatory mechanisms underlying the metabolism of gut-
derived 5-HT are incompletely understood. Here, we demon-
strate that the gut microbiota plays a key role in promoting levels
of colon and blood 5-HT, largely by elevating synthesis by host
ECs. This host-microbiota interaction contributes to a growing
appreciation that the microbiota regulates many aspects of GI
physiology by signaling to host cells. Whether particular mem-
bers of the microbiota contribute 5-HT by de novo synthesis re-
mains unclear. Some bacteria, including Corynebacterium spp.,Streptococcus spp., and Escherichia coli, are reported to syn-
thesize 5-HT in culture (Roshchina, 2010), but this is believed
to occur independently of Tph, by decarboxylation of tryptophan
to tryptamine (Williams et al., 2014), as seen in plants (Oleskin
et al., 1998). Our finding that colonic PCPA administration blocks
the ability of the microbiota to promote colonic and blood 5-HT
(Figures 3C and 3D) suggests that gut microbes require host
Tph activity to upregulate peripheral 5-HT. Furthermore, SPF
Tph1 KOmice lack >90%of intestinal and blood 5-HT levels (Sa-
velieva et al., 2008), indicating that <10% of peripheral 5-HT is
contributed directly by microbial synthesis or by Tph2-mediated
biosynthesis in thesemice. We find that the microbiota regulates
relatively high levels of peripheral 5-HT, 64%of colonic (Figure 1),
and 49%of serum concentrations (Figure 1) (Sjo¨gren et al., 2012;
Wikoff et al., 2009), further supporting the notion that the micro-
biota modulates 5-HT metabolism primarily by affecting host
colonic ECs. Consistent with the understanding that ECs secrete
low levels of 5-HT into the lumen, fecal concentrations of 5-HT
are also significantly increased by the microbiota. Interestingly,
5-HT is reported to stimulate the growth of Enterococcus faeca-
lis, E. coli, and Rhodospirillum rubrum in culture (Oleskin
et al., 1998; Tsavkelova et al., 2006). In addition, 5-HT is a struc-
tural analog of auxins found in E. faecalis, R. rubrum, and Staph-
ylococcus aureus, among other bacteria. Whether particular
members of the microbiota alter host 5-HT biosynthesis to, in
turn, support colonization, growth, or resilience of particular
gut microbes is an interesting question for future study.
We demonstrate that indigenous spore-forming microbes
from colons of SPF mice (Sp) and from a healthy human
colon (hSp) sufficiently mediate microbiota effects on colonic
and blood 5-HT. While we show that B. fragilis, B. uniformis,
SFB, ASF, and a consortium of Bacteroides species cultured
from mice, including B. thetaiotaomicron, B. acidifaciens, and
B. vulgatus, have no effect on host peripheral 5-HT (Figure 3),
whether other non-Sp microbial species or communities are
capable of modulating colonic and serum 5-HT remains unclear.
Interestingly, Sp and hSp are known to promote regulatory T cell
levels in the colons, but not small intestines, of GF and SPF mice
(Atarashi et al., 2013). This regional specificity is also seen with
microbiota-induced 5-HT biosynthesis, which occurs in colonic,
but not small intestinal, ECs (Figures S1A, S2A, and S2B). We
find that Sp elevates colon 5-HT levels even in Rag1 KO mice
(Figure S2G), indicating that the serotonergic effects of Sp are
not dependent on T and B cells. Whether 5-HT modulation con-
tributes to the immunosuppressive effects of Sp, however, is un-
clear. In light of increasing evidence that innate and adaptive im-
mune cells express a variety of 5-HT receptors (Baganz and
Blakely, 2013), future studies examining whether Sp-mediated
increases in peripheral 5-HT levels impact cellular immune re-
sponses will be of interest.
Consistent with our finding that the microbiota modulates co-
lon and serum 5-HT via interactions with host colonic ECs, we
find that particular fecal metabolites are similarly elevated by
SPF, Sp, and hSp microbiota and sufficiently promote 5-HT in
chromaffin cell cultures and in vivo (Figure 6; Table S1). Deoxy-
cholate is a secondary bile acid, produced bymicrobial biotrans-
formation of cholate. In addition to facilitating lipid absorption, it
has endocrine, immunological, and antibiotic effects and isCell 161, 264–276, April 9, 2015 ª2015 Elsevier Inc. 271
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Figure 6. Microbial Metabolites Mediate Effects of the Microbiota on Host Serotonin
(A) Levels of 5-HT released from RIN14B cells after exposure to colonic luminal filtrate from SPF, GF, and Sp-colonized mice, or to ionomycin (iono). Data are
normalized to 5-HT levels in vehicle-treated controls (hatched gray line at 1). Asterisks directly above bars indicate significance compared to controls; asterisks at
the top of the graph denote significance between experimental groups (n = 3).
(B) Expression of TPH1 relative to GAPDH in RIN14B cells after exposure to colon luminal filtrate from SPF, GF and Sp-colonized mice, or to ionomycin (iono).
Data are normalized to gene expression in vehicle-treated controls (hatched gray line at 1). Asterisks directly above bars indicate significance compared to
controls, whereas asterisks at the top of the graph denote significance between experimental groups (n = 4).
(C) Principal components analysis of the fecal metabolome from GF mice colonized with SPF, ASF, Sp, or hSp (n = 6).
(D) Levels of 5-HT released from RIN14B cells after exposure to metabolites: acetate (1 mM), a-tocopherol (8 uM), arabinose (50 uM), azelate (50 uM), butyrate
(100 uM), cholate (75 uM), deoxycholate (25 uM), ferulate (25 uM), GABA (25 uM), glycine (50 uM), N-methyl proline (0.5 uM), oleanolate (50 uM), p-aminobenzoate
(1 uM), propionate (100 uM), taurine (50 uM), and tyramine (100 uM). Data are normalized to 5-HT levels in vehicle-treated controls (gray line at 1) (n = 5–19).
(E) Expression of TPH1 relative toGAPDH in RIN14B cells after metabolite exposure. Data are normalized to expression in vehicle-treated controls (gray line at 1)
(n = 3–4).
(F) Levels of 5-HT in colons (left) and serum (center) of GF mice at 30 min after intrarectal injection of deoxycholate (125 mg/kg) or vehicle. Expression of TPH1
relative to GAPDH (right) at 1 hr post injection (n = 3–8).
(legend continued on next page)
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reported to modulate the microbiota (Islam et al., 2011) and the
severity of Clostridium difficile and Camphylobacter jejuni infec-
tions (Buffie et al., 2014; Malik-Kale et al., 2008). Detrimental ef-
fects are also observed; deoxycholate exhibits carcinogenic
properties and is linked to various cancers (Bernstein et al.,
2011; Yoshimoto et al., 2013). Notably, deoxycholate is reported
to promote GI motility by activating TGR5 G protein-coupled re-
ceptors on ECs (Alemi et al., 2013), which is consistent with our
finding that Sp-induced metabolites raise 5-HT levels in ECs and
that Sp colonization improves GI motility. Particular Clostridium
species are known to possess high 7a-dehydroxylation activity
required for the production of deoxycholate from cholate (Kita-
hara et al., 2001; Narushima et al., 2006), which is in line with
our finding that Sp microbes, comprised largely of Clostridia, in-
crease deoxycholate levels. Deoxycholate concentrations are
substantially higher in the colon versus small intestine (Sayin
et al., 2013), which, coupled to the finding that bacterial load
and diversity is greater in the colon versus small intestine (Se-
kirov et al., 2010), could contribute to the regional specificity of
microbiota-mediated increases in 5-HT synthesis to colonic
ECs. Phylogenetic analysis of 16S rDNA sequences reveals
that a subset of microbes recovered from Sp-colonized mice
cluster taxonomically with known 7a-dehydroxylating Clostridia
(Figures 6G and S7). Notably, there are striking phylogenetic
commonalities between taxa identified in Sp- and hSp-colonized
mice (Figure S7), consistent with their very similar luminal metab-
olomic profiles (Figure 6C) and ability to promote 5-HT synthesis
from colonic ECs (Figure S3).
We also reveal that the metabolites a-tocopherol, tyramine,
and PABA are elevated in feces by Sp. hSp or SPF colonization
co-vary with fecal 5-HT levels and sufficiently induce 5-HT
in vitro and in vivo (Figures 6 and S6; Table S1). a-tocopherol
is a naturally abundant form of vitamin E, with reported thera-
peutic effects for several diseases (Brigelius-Flohe and Traber,
1999). Interestingly, patients with depression exhibit decreased
plasma a-tocopherol (Maes et al., 2000; Owen et al., 2005),
and treatment with a-tocopherol reduces depressive-like be-
havior in pre-clinical models (Lobato et al., 2010), suggesting a
link between a-tocopherol and 5-HT-related disease. Tyramine
is a trace amine that acts as a neurotransmitter and catechol-
amine-releasing agent. Particular bacteria can produce tyramine
by decarboxylation of tyrosine in the gut, where tyramine is re-
ported to stimulate fast ileal contractions and neuropeptide Y
release (Marcobal et al., 2012). PABA is an intermediate of folic
acid synthesis and essential nutrient for some bacteria. Partic-
ular species can generate PABA from chorismate (de Cre´cy-La-
gard et al., 2007), but physiological roles for PABA in the GI tract
are unclear. Subsets of microbes from Sp- and hSp-colonized
mice relate phylogenetically to Clostridia with putative genes
for a-tocopherol and tyrosine metabolism (Figures 6G and S7).
Screening Sp microbes for target metabolic functions could(G) Phylogenetic tree displaying key Sp. (M) and hSp. (H) operational taxonomic
droxylation activity (red circles). Relative abundance is indicated in parentheses
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p <
tionally-colonized); GF, germ-free; Sp, spore-forming bacteria; iono, 15 uM io
bacteria.
See also Figures S6 and S7.serve as a tractable approach for further parsing the Sp con-
sortium into the minimal species required for increasing 5-HT
biosynthesis by ECs.
While there is increasing evidence for a bi-directional rela-
tionship between the gut microbiota and gut sensorimotor
function, the particular microbes and mechanisms involved
are unclear. The microbiota is required for normal IPAN excit-
ability (McVey Neufeld et al., 2013), and recent studies reveal
that changes in the microbiota can alter levels of neuroactive
molecules, such as nitric oxide, substance P and endocannabi-
noids, which have the potential to influence gut motor activity
(Quigley, 2011). Mucosal immune responses (Collins, 1996),
including key interactions between macrophages and enteric
neurons (Muller et al., 2014), also modulate GI motility via the
gut microbiota. It will be interesting to determine whether 5-
HT-mediated effects on immunity (Baganz and Blakely, 2013)
contribute to its effects on GI motility. Notably, deconjugated
bile salts are reported to alter gut sensorimotor activity (Ap-
pleby and Walters, 2014), which supports our hypothesis that
Sp-induced increases in deoxycholate, among other metabo-
lites, contribute to its ability to elevate colonic 5-HT and
decrease intestinal transit time.
While we demonstrate that Sp-mediated induction of colonic
and blood 5-HT regulates GI motility and platelet function in
mice, further research is needed to explore additional implica-
tions of microbially induced 5-HT on host health and disease
(O’Mahony et al., 2015). Peripheral 5-HT modulates several
cellular processes, including osteoblast differentiation, eryth-
ropoiesis and immunity. Moreover, gross abnormalities in brain
structure are observed in Tph1+/ embryos from Tph1/
mothers (Coˆte´ et al., 2007), indicating that maternal peripheral
5-HT is important for offspring neurodevelopment. Placentally-
derived 5-HT also influences neurodevelopment, influencing
thalamocortical axon guidance (Bonnin et al., 2011). Interest-
ingly, the indigenous microbiota also modulates hippocampal
levels of 5-HT (Clarke et al., 2013), revealing a role for the mi-
crobiota in regulating the brain serotonergic system. Overall,
our findings provide a mechanism by which select microbes
and their metabolic products can be used to promote endoge-
nous, localized 5-HT biosynthesis and further alter host
physiology.EXPERIMENTAL PROCEDURES
See Supplemental Information for additional details and references.PCPA Treatment
At 2 weeks post-bacterial treatment, mice were anesthetized with isoflurane,
and PCPA (90 mg/kg) (Liu et al., 2008) was administered intrarectally every
12 hr for 3 days using a sterile 3.5 Fr silicone catheter inserted 4 cm into the
rectum. Mice were suspended by tail for 30 s before return to the homeunits (OTUs) relative to reference Clostridium species with reported 7a-dehy-
(n = 3).
0.0001. n.s., not statistically significant; SPF, specific pathogen-free (conven-
nomycin; ASF, Altered Schaedler Flora; hSp, human-derived spore-forming
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cage. For mock treatment, mice were anesthetized and intrarectally injected
with sterile water as vehicle.
Serotonin Measurements
Serotonin levels were detected in sera and supernatant of tissue homogenates
by ELISA according to the manufacturer’s instructions (Eagle Biosciences).
Readings from tissue samples were normalized to total protein content as de-
tected by BCA assay (Thermo Pierce). Data compiled across multiple experi-
ments are expressed as 5-HT concentrations normalized to SPF controls
within each experiment.
RIN14B In Vitro Culture Experiments
RIN14B cells (ATCC) were seeded at 105 cells/cm2 and cultured according to
methods described in Nozawa et al. (2009). Total colonic luminal contents
were collected from adult SPF, GF, and GFmice colonized with spore-forming
bacteria, suspended at 120 ml/mg in HBSS supplemented with 0.1% BSA and
2 uM fluoxetine, and centrifuged at 12,000 3 g for 10 min. Supernatants were
passed through 0.2 um pore syringe filters. Cultured RIN14B cells were incu-
bated with colonic luminal filtrate for 1 hr at 37C.
GI Transit Assay
Mice were orally gavaged with 200 ml sterile solution of 6% carmine red (Sigma
Aldrich) and 0.5%methylcellulose (Sigma Aldrich) in water and placed in a new
cage with no bedding (Li et al., 2011). Starting at 120 min post-gavage, mice
were monitored every 10 min for production of a red fecal pellet. GI transit
time was recorded as the total number of minutes elapsed (rounded to the
nearest 10 min) before production of a red fecal pellet. For mice treated intra-
rectally with PCPA or metabolites, GI transit assay was conducted 1 hr after
the third injection.
Platelet Activation and Aggregation Assays
Blood samples were collected by cardiac puncture, diluted with a 23 volume
of HEPES medium and centrifuged through PST lithium hepararin vacu-
tainers (Becton Dickinson). Expression of platelet activation markers was
measured by flow cytometry (Nieswandt et al., 2004; Ziu et al., 2012). Platelet
aggregation assays were conducted according to methods described in (De
Cuyper et al., 2013). Remaining unstained PRP was used to generate PRP
smears. Slides were stained with Wright Stain (Camco) according to stan-
dard procedures.
16S rRNA Gene Sequencing and Analysis
Fecal samples were collected at 2 weeks after orally gavaging GFmice with Sp
or hSp. Bacterial genomic DNA was extracted from mouse fecal pellets using
the QIAamp DNA Stool Mini Kit (QIAGEN). The library was generated accord-
ing to methods from (Caporaso et al., 2011). The V4 regions of the 16S rRNA
gene were PCR amplified, purified and then sequenced using the Illumina
MiSeq platform. Operational taxonomic units (OTUs) were chosen de novo
with UPARSE pipeline (Edgar, 2013). Taxonomy assignment and rarefaction
were performed using QIIME1.8.0 (Caporaso et al., 2010). Phylogenetic trees
were built using PhyML (Guindon et al., 2010) and visualized using iTOL (Le-
tunic and Bork, 2007).
See also Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Discussion, Extended Experi-
mental Procedures, seven figures, and four tables and can be found with
this article online at http://dx.doi.org/10.1016/j.cell.2015.02.047.
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